NewGenIvf Group Limited
NIVF · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $1 | $1 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $1 | $1 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 5.8% | -13.6% | 44.3% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 33.6% | 32.7% | 25.9% | 24.9% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 0.4% | 7.5% | 12.2% | 14.3% |
| Net Income | -$0 | $0 | $0 | -$0 |
| % Margin | -9.7% | 2.5% | 7.7% | -0% |
| EPS Diluted | -115.25 | 64.25 | 323 | -0.025 |
| % Growth | -279.4% | -80.1% | 1,292,100% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | $0 |